PainReform shares surge 61.15% intraday after rebranding to PRF Technologies and expanding into specialty pharma, ophthalmology, and AI-driven energy analytics.

PainReform Ltd. (NASDAQ:PRFX) surged 61.15% intraday after rebranding to PRF Technologies Ltd., signaling a strategic pivot to diversify its portfolio into specialty pharmaceuticals, ophthalmology, and AI-driven renewable energy analytics. The name change, announced to reflect the company’s expanded focus, coincided with a massive 35.49 million trading volume—far exceeding its 672.85k average—indicating heightened market interest. The stock’s rally aligned with positive technical indicators, including a 21.12% rise above its 20-day moving average and a bullish MACD, while Phase I safety data for OcuRing-K and DeepSolar’s renewable energy platform underscored growth potential. The move mirrored broader small-cap volatility, with speculative momentum driving the intraday spike amid a narrative of long-term value diversification.